Legend Biotech (LEGN)
(Delayed Data from NSDQ)
$45.30 USD
+0.88 (1.98%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $45.30 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO5/13/24 |
---|---|
Current Quarter | -0.24 |
EPS Last Quarter | -0.40 |
Last EPS Surprise | 42.86% |
ABR | 1.33 |
Earnings ESP
|
-31.47% |
---|---|
Current Year | -1.35 |
Next Year | 0.08 |
EPS (TTM) | -1.24 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 152.60M | 117.04M | 574.48M | 1.17B |
# of Estimates | 5 | 5 | 6 | 6 |
High Estimate | 187.90M | 159.70M | 653.40M | 1.53B |
Low Estimate | 80.00M | 85.00M | 450.00M | 875.00M |
Year ago Sales | 36.34M | 73.33M | 285.14M | 574.48M |
Year over Year Growth Est. | 319.92% | 59.61% | 101.47% | 103.43% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.24 | -0.42 | -1.35 | 0.08 |
# of Estimates | 6 | 6 | 8 | 7 |
Most Recent Consensus | -0.10 | -0.34 | -1.09 | 0.36 |
High Estimate | -0.01 | -0.12 | -0.43 | 2.14 |
Low Estimate | -0.75 | -0.77 | -2.73 | -1.71 |
Year ago EPS | -0.40 | -0.27 | -1.47 | -1.35 |
Year over Year Growth Est. | 40.00% | -55.56% | 8.16% | 105.93% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 0 |
Up Last 60 Days | 2 | 1 | 4 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 3 | 3 | 3 | 2 |
Down Last 60 Days | 2 | 3 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.24 | -0.42 | -1.35 | 0.08 |
7 Days Ago | -0.24 | -0.42 | -1.35 | 0.08 |
30 Days Ago | -0.23 | -0.39 | -1.39 | 0.12 |
60 Days Ago | -0.41 | -0.49 | -1.74 | 0.83 |
90 Days Ago | -0.41 | -0.49 | -1.74 | 0.83 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.31 | -0.41 | -1.25 | -0.17 |
Zacks Consensus Estimate | -0.24 | -0.42 | -1.35 | 0.08 |
Earnings ESP | -31.47% | 3.15% | 7.41% | -312.50% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.40 | -0.17 | -0.27 | -0.40 | NA |
Estimate | -0.70 | -0.56 | -0.69 | -0.56 | NA |
Difference | 0.30 | 0.39 | 0.42 | 0.16 | 0.32 |
Surprise | 42.86% | 69.64% | 60.87% | 28.57% | 50.49% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more